People

Kenneth Zhou

Partner

Zhou, Kenneth

Kenneth Zhou's practice focuses on foreign direct investment, cross-border mergers and acquisitions, joint ventures and strategic alliance, general corporate, antitrust and regulatory matters, FCPA and investigations, and international dispute resolution. He has advised foreign companies in high-tech, media and entertainment, telecommunications, pharmaceuticals, healthcare, banking and financial services, publishing, consumer product and services industries with respect to their strategic expansion in China.

Practice

Mr. Zhou has also advised leading Chinese companies on their outbound investments, M&A and strategic expansion in the US and Europe. In addition, he is also experienced in private equity and venture capital transactions, capital market, foreign trade and WTO matters.

Prior to joining the firm, Mr. Zhou was a corporate attorney and a member of the China Practice Group at Paul Weiss Rifkind Wharton & Garrison LLP, where he worked in New York, Hong Kong and Beijing.

Before Paul Weiss, Mr. Zhou participated in the establishment of AllBright Law Offices, a leading law firm in China. He also served as general counsel of Shanghai Alliance Investment Limited, the investment arm of the Shanghai Municipal Government.

Publications & News

View

April 21, 2014

MOFCOM to Publicize Administrative Penalties for Illegal Implementation of Concentrations

To increase the incentives for compliance in the name of transparency of law enforcement, China’s Ministry of Commerce (“MOFCOM”) has decided to publicize its decisions to penalize companies which fail to notify concentrations that meet the regulatory thresholds for notifications under China’s Anti-Monopoly Law (the “AML”).

April 4, 2014

Reforms to China's Company Registration Law

Both the amended Company Law and the amended Registration Regulations took effect on March 1, 2014. These reforms create a simplified and more capital-efficient registration system with respect to registered capital and regulatory requirements for companies in China.

March 28, 2014

SAIC Announces Beginning of Revision Process to Anti-Unfair Competition Law

China's State Administration for Industry and Commerce (SAIC) has announced that it has formally begun the task of revising the Anti-Unfair Competition Law (AUCL). SAIC's Anti-Monopoly and Anti-Unfair Competition Enforcement Bureau held the first revision session in Beijing on February 28.

March 27, 2014

Lester Ross Elected as Vice Chairman of the Board of Governors of AmCham China

Lester Ross, partner-in-charge of the firm’s Beijing office, has been elected Vice Chairman of the Board of Governors of the American Chamber of Commerce in the People’s Republic of China (AmCham China).

February 20, 2014

China Establishes Expedited Preliminary Merger Review Procedure

Companies subject to a merger notification obligation in China have long been frustrated by the extensive delays beyond the 30-day Phase 1 period even for simple, non-controversial transactions.

January 9, 2014

China’s New Anti-Corruption Policies in the Health Care Industry

July 22, 2013

Lawyers Weigh Impact of China's GSK Case

An article by The American Lawyer, featuring commentary from WilmerHale Partner Kenneth Zhou on the GlaxoSmithKline case and anti-bribery enforcement in China.

July 1, 2013

Administrative and Civil Litigation under the Anti-Monopoly Law

A chapter by Lester Ross and Kenneth Zhou, published in China’s Anti-Monopoly Law: The First Five Years, Chapter 19, pp. 317-333.

April 26, 2013

China Clears Glencore's Acquisition of Xstrata Subject to Remedies

January 28, 2013

Chinese Government Plans Consolidation of Domestic Industry

Speaking Engagements

Professional Activities

Mr. Zhou currently serves as associate general counsel of the American Chamber of Commerce – People's Republic of China.

Publications

Mr. Zhou is the author of the Business Organization Chapter published in Business Law in China: Trade, Investment, Operations and Finance. ICC Publ. No. 672, 2d rev. ed. He is also one of the authors of China’s Anti-Monopoly Law – The First Five Years, published by Wolters Kluwer in 2012. He has written articles in such periodicals as China Law & Practice, Asia Pacific Antitrust and Trade Review, Capital and others on a wide range of topics including M&A, corporate restructuring, private equity/venture capital investment, foreign direct investment in China, tax and regulatory matters.

Mr. Zhou was interviewed and spoke at events organized by CNN, Bloomberg, CCTV, The American Lawyer, Cai Jin Magazine, South China Morning Post, American Chamber of Commerce China, 21st Century, Top Capital, Association of Insolvency and Restructuring Advisors (AIRA), Asia Risk, and others on a variety of topics including cross-border M&A, anti-monopoly filings in China, equity financing, outbound investments of Chinese companies, dispute resolution, PE/VC investments, Internet law, SOE restructuring, qualified foreign institutional investors (QFII), qualified foreign limited partnership (QFLP), VIE structures, anti-monopoly law and national security review.

Practices

Skip Navigation Links.

Education

LLM, New York University School of Law, Editor, Commentator

LLB, with honors, East China University of Politics and Law

Bar Admissions

PRC National Bar

New York

Languages

Chinese (Mandarin)

Shanghainese

English